Form 4: Zimmer Biomet SVP Reports RSU Vesting and Tax Sale

Chad F. Phipps, Senior Vice President at Zimmer Biomet, reported the vesting of restricted stock units and a subsequent sale of shares to cover tax obligations.

Summary

• Chad F. Phipps, Senior Vice President, Chief Legal, Corporate Affairs and Secretary of Zimmer Biomet Holdings, Inc. (ZBH), reported transactions on February 25, 2026.
• 2,626 shares of Common Stock were acquired through the vesting of Restricted Stock Units (RSUs) at a price of $0.
• 1,057 shares of Common Stock were disposed of at a price of $99.51 to satisfy tax withholding obligations related to the RSU vesting.
• Following these transactions, Phipps beneficially owns 63,706 shares of Common Stock directly.
• One-third of the RSUs vested on February 25, 2026, with the remaining RSUs scheduled to vest one-half on February 25, 2027, and one-half on February 25, 2028.
• After the vesting, 5,249 derivative Restricted Stock Units remain beneficially owned.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a routine compensation event for an executive, reflecting standard equity incentive practices and not indicating any significant positive or negative operational developments.

Positives

• The vesting of 2,626 Restricted Stock Units (RSUs) represents a component of executive compensation, aligning management's interests with shareholder value.

Negatives

• 1,057 shares of Common Stock were sold at $99.51 to cover tax withholding obligations, resulting in a reduction of direct beneficial ownership.

Future Outlook

The remaining Restricted Stock Units are scheduled to vest one-half on February 25, 2027, and the final one-half on February 25, 2028.

Management Comments

• Chad F. Phipps holds the title of Senior Vice President, Chief Legal, Corporate Affairs and Secretary.

Industry Context

StockSavvy.ai notes that the vesting of Restricted Stock Units (RSUs) and subsequent sales to cover tax obligations are standard practices in executive compensation across various industries, designed to align executive incentives with long-term company performance.

Stakeholder Impact

• Shareholders: The transaction is a routine executive compensation event and tax-related sale, which typically has a minor, neutral impact on overall shareholder value or perception.

Next Steps

• Scheduled vesting of remaining Restricted Stock Units: one-half on February 25, 2027, and the final one-half on February 25, 2028.

Key Dates

Keywords

Zimmer Biomet Holdings Inc., ZBH, Form 4, Insider Transaction, Restricted Stock Units, RSU Vesting, Executive Compensation, Chad F. Phipps, Stock Sale, Tax Withholding